Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

"Our results identify potentially disease-facilitating bacteria sampled from the ileum of multiple sclerosis affected twins," ...

His research shows molecular changes in brain cells when a person develops multiple sclerosis (MS). But it is still unclear ...

Scientiam Pharma has disclosed new 6-aminophenanthridine derivatives acting as Epstein-Barr nuclear antigen 1 (EBNA-1) inhibitors reported to be useful for the treatment of Epstein-Barr virus ...

In 2024, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress celebrated a remarkable 40 years of pioneering work. Regional committees have emerged around the ...

Epstein-Barr Virus Epstein-Barr virus (EBV) has long been postulated to play a role in the pathogenesis of MS, but that connection received a solid boost in 2022, when Alberto Ascherio, MD, DrPH ...